Alterations of renal V1 and V2 receptors in spontaneously hypertensive rats and doca-salt hypertensive rats using computerized quantification for macro-autoradiogram

Research Communications in Molecular Pathology and Pharmacology

Volumn 95, Issue 1, 1997, Pages 43-56

  Mimura, Yukari ^a   Ogura, Toshio ^a   Kataoka, Hideo ^a   Oishi, Teisuya ^a   Asano, Naoko ^a   Kishida, Masayuki ^a   Yamauchi, Takayoshi ^a   Ogawa, Norio ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN; ARGIPRESSIN DERIVATIVE; DEOXYCORTICOSTERONE ACETATE; MOZAVAPTAN; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; VASOPRESSIN RELEASE;

ANIMALS; AUTORADIOGRAPHY; BODY WEIGHT; DESOXYCORTICOSTERONE; HYPERTENSION; KIDNEY; MALE; ORGAN SIZE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, VASOPRESSIN;

EID: 0031038240     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Berecek, K.H., Barron, K.W., Webb, R.L. and Brody, M.J. (1982). Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension Dallas 4(suppl II):131-137.
2. Burrell, L.M., Phillips, P.A., Stephenson, J.M., Risvanis, J., Rolls, K.A. and Johnson, C.I. (1994). Blood Pressure-Lowering Effect of an Orally Active Vasopressin V1 Receptor Antagonist in Mineralocorticoid Hypertension in the Rat. Hypertension 23:737-743.
3. Crofton, J.T., Share, L., Shade, RE, Alien, C. and Tarnowski, D. (1978). Vasopressin in the rat with spontaneous hypertension. Am. J. Physiol. 235:H361-H366.
4. Crofton, J.T., Share, L., Shade, R.E., Lee-Kwon, W.J., Manning, M. and Sawyer, W.H. (1979). The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension 1:31-38.
5. Crofton, J.T., Share, L., Wang, B.C. and Shade, R.E. (1980). Pewssor Responsiveness to Vasopressin in the Rat with DOC-Salt Hypertension. Hypertension 2:424-431.
6. Datar, S., Chiu, E.K.Y. and McNeil, J.R. (1985). Reflexes fail to reduce presser activity of vasopressin in spontaneous hypertension. Am. J. Physiol. 248:H49-H59.
7. Ganten, U., Rascher, W., Lang, R.E., Dietz, R., Retting, R., Unger, T., Taugner, R. and Ganten, D. (1983). Development of a new strain of spontaneously hypertensive rats homozygous for hypothalamic diabetes insipidus. Hypertension 5(suppl I):I-119-I128.
8. Hofbauer, K.G., Mah, S.C, Baum, H.P., Hanni, H., Wood, J.M. and Kraetz, J. (1984). Endocrine control of salt and water excretion: the role of vasopressin in DOCA-salt hypertension. J. Cardiovasc.Pharmacol. 6(suppl 1):S184-S191.
9. Hosoya, M., Ogura, T., Watanabe, H., Ota, Z. and Kageyama, Z. (1996). Autoradiographic Localization and Age-Related Changes in Vasopressin Receptors in Spontaneously Hypertensive Rats. Nephron 72:281-287.
10. Ishikawa, S., Goldberg, J.P., Schrier, D.M, Aisenbrey, G.A. and Schrier, R.W. (1984). Interrelationship between Subpressor Effects of Vasopressin and Other Vasoactive Hormones in the Rat. Mineral Electrocyte Metab 10: 184-189.
11. Lariviere, R., St-Louis, J. and Schiffrin, E.L. (1988), Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats. J Hypertension 6:211-217.
12. Mimura, Y., Ogura, T., Yamauchi, T., Otsuka, F., Oishi, T., Harada, K., Hashimoto, M. and Ota, Z. (1995). Effect of Vasopressin-V1 and V2 receptor stimulation on blood pressure in DOCA-salt hypertensive rats. Acta Med Okayama 49: 187-194.
13. Mohring, J. (1978). Neurohypophyseal vasopressor principle. Vasopressor hormone as well as antidiuretic hormone. Klin Wochensch 56(suppl I):71-79.
14. Mohring, J., Kitz, J. and Schoun, J. (1978). Role of vasopressin in blood pressure control of spontaneously hypertensive rat. Clin. Sci. Mol. Med. 55:247s-250s.
15. Morris, M., Keller, M and Sundberg, D.K. (1983). Changes in paraventricular vasopressin and oxytocin during the development of spontaneous hypertension. Hypertension Dallas 5:476-481.
16. Nishida, N., Ogura, T., Yamauchi, T., Hosoya, M. and Ota, Z. (1994). Treatment with cilazapril, angiotensin-converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat. Res. Commun. Chem. Patho. Pharmacol. 84: 143-152.
17. Ogura, T., Mitsui, T., Yamamoto, I., Katayama, E., Ota, Z. and Ogawa, N. (1987). Differential changes in atrial natriuretic peptide and vasopressin receptor bindings in kidney of spontaneously hypertensive rat. Life Sciences 40:233-238.
18. Ogura, T., Nishida, N., Watanabe, H., Omiya, T., Yamauchi, T., Hosoya, M., Hirata, H., Kashihara, N. and Ota, Z. (1994). Alteration of Renal Receotor for Atrial Natriuretic Peptide and Vasopressin in Spontaneously Hypertensive Rats Treated with Antihypertensive Diuretics. Res. Commun. Chem. Patho. Pharmacol. 83: 165-178.
19. Ogura, T., Yamarnoto, I. and Ogawa, N. (1989). Developmental Change of Kidney Receptor for Atrial Natriuretic Factor in Spontaneously Hypertensive Rat. Hypertension 13:449-455.
20. Okada, H., Suzuki, H., Kanno, Y., Yamamura, Y. and Saruta, T. (1994). Chronic and selective vasopressin blockade in spontaneously hypertensive rats. Am. J. Physiol. 267:R1467-R1471.
21. Okada, K., Ishikawa, S. and Saito, T. (1993). Enhancement of intracellular sodium by vasopressin in spontaneously hypertensive rats. Hypertension Dallas 22:300-305.
22. Saito, T. and Y. Yajima, Y. (1982). Development of DOCA-salt hypertension in the Brattleboro rat. Ann. NY. Acad. Sci. 394:309-317.
23. Simon, J.S., Brody, M.J. and Kasson, E.G. (1992) Characterization of a vasopressin-like peptide in rat and bovine blood vessels. Am. J. Physiol. 262:H799-H805.
24. Sladek, C.D., Blair, M.L., Sterling, C. and Mangiapane, M.L. (1988). Attenuation of Spntaneous Hypertension in Rats by a Vasopressin Antagonist. Hypertension 12:506-512.
25. Tabrizchi, R. and Triggle, C.R. (1991). Presser actions of arginine vasopressin in pithed Sprague-Dawley, Wistar-Kyoto and spontaneously hypertensive rats before and after treatment with nifedipine or pertussis toxin. J. Hypertens. 9:813-818.
26. Takatori, K., Ogura, T. and Ota, Z. (1991a). Computerized approach usion autoradiography to quantify atrial natriuretic peptide receptors in the DOCA-salt hypertensive ratkidney. Regul. Pept. 35:115-125.
27. 3H]-yohinbine binding studies. J. Int. Med. Res. 19: 153-160.
28. Wuthrich, R.P. and Vallotton, M.B. (1986). Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells. Am. J. Physiol. 251:F499-F505.
29. Yamauchi, T., Ogura, T., Oishi, T., Harada, K., Hashimoto, M., Mimura, Y., Asano, N., Ota, Z. and Kageyama, J. (1995). Enhanced pressor response in spontaneously hypertensive rats induced by stimulation-V1 receptors. Acta Med Okayama 49: 53-59.